Cargando…

Effects of endotoxin elimination therapy using polymyxin B immobilized fiber in patients with septic shock after surgical operation

Detalles Bibliográficos
Autores principales:	Ikeda, T, Ikeda, K, Kaneko, H, Kamei, T, Kamisato, K, Ishii, N, Matsuno, N, Nagao, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1997
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495496/ http://dx.doi.org/10.1186/cc52

Ejemplares similares

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock
por: Shoji, Hisataka, et al.
Publicado: (2021)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
por: Ikeda, T, et al.
Publicado: (2012)

Efficacy of the endotoxin absorption method (PMX) in patients with septic shock associated with intraperitoneal infections
por: Ikeda, T, et al.
Publicado: (2000)

Anti-endotoxin Properties of Polymyxin B-immobilized Fibers
por: Tani, Tohru, et al.
Publicado: (2019)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

Pan-peritonitis due to intestinal perforation, and efficacy of direct hemoperfusion with polymyxin B immobilized fiber (PMX-20R)
por: Ikeda, T
Publicado: (1999)

Clinical efficacy of long-term performance with polymyxin-B immobilized fiber treatment for septic shock
por: Matumoto, N, et al.
Publicado: (2008)

Removing endocannabinoids and reducing oxidative stress with polymyxin-B-immobilized fibers in patients with septic shock
por: Kase, Y, et al.
Publicado: (2007)

Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock
por: Mitaka, Chieko, et al.
Publicado: (2021)

Increase in systolic blood pressure and improvement in laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock
por: Sakamoto, Y, et al.
Publicado: (2010)

Polymyxin B hemoperfusion in high endotoxin activity level septic shock patients
por: Monti, G, et al.
Publicado: (2008)

History and current status of polymyxin B‐immobilized fiber column for treatment of severe sepsis and septic shock
por: Shimizu, Tomoharu, et al.
Publicado: (2017)

Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2006)

Clinical effects of polymyxin B immobilised fiber with direct hemoperfusion for the patients of severe sepsis or septic shock caused by intra-abdominal infections
por: Ikeda, T, et al.
Publicado: (2009)

Use of extracorporeal endotoxin elimination therapy for septic shock
por: Adamik, BA, et al.
Publicado: (2013)

Endotoxin Elimination in Patients with Septic Shock: An Observation Study
por: Adamik, Barbara, et al.
Publicado: (2015)

White blood cell counts have an impact on septic patient outcome followed by polymyxin-b immobilized fiber with direct hemoperfusion
por: Tanaka, H, et al.
Publicado: (2015)

Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy
por: Ikeda, T, et al.
Publicado: (2005)

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
por: Honore, Patrick M., et al.
Publicado: (2018)

Effectiveness of polymyxin b immobilized fiber hemoperfusion in patients with septic shock due to Gram-negative bacillus infection: the PMXHP study
por: Saito, N, et al.
Publicado: (2015)

Endotoxin removal therapy with Polymyxin B immobilized fiber column as a COVID-19-bedside strategy protocol for endotoxic shock
por: De Rosa, Silvia, et al.
Publicado: (2022)

Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
por: Yamashita, C, et al.
Publicado: (2011)

Is polymyxin B-immobilized fiber column ineffective for septic shock? A discussion on the press release for EUPHRATES trial
por: Iba, Toshiaki, et al.
Publicado: (2017)

Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection
por: Saito, Nobuyuki, et al.
Publicado: (2017)

A successful application of adult polymyxin B-immobilized fiber column hemoperfusion to a neonate with septic shock
por: Kim, Young A, et al.
Publicado: (2019)

Effects of nitric oxide on hemodynamic changes and metabolism following acute hepatic inflow occlusion in pigs
por: Ikeda, T, et al.
Publicado: (1997)

Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
por: Sugiura, Makiko, et al.
Publicado: (2015)

Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours
por: Mitaka, C, et al.
Publicado: (2012)

Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
por: Ikeda, T, et al.
Publicado: (2004)

Immunomodulation in Sepsis: The Role of Endotoxin Removal by Polymyxin B-Immobilized Cartridge
por: Esteban, Elisabeth, et al.
Publicado: (2013)

Use of Direct Hemoperfusion with Polymyxin B-Immobilized Fiber for the Treatment of Septic Shock Complicated with Lemierre Syndrome Caused by Fusobacterium necrophorum
por: Kodama, Yoshiyuki, et al.
Publicado: (2019)

Investigation of type II phospholipase A(2 )values and eicosanoid values during polymyxin-B-immobilized fiber direct hemoperfusion of septic shock patients
por: Shouzushima, T, et al.
Publicado: (2009)

Efficacy of endotoxin absorption therapy on sepsis by polymyxin B-attached fibers
por: Atagi, K
Publicado: (2011)

Does transforming growth factor-β inhibit nitric oxide synthesis and prevent septic shock?
por: Endo , S, et al.
Publicado: (1999)

The role of plasminogen activator inhibitor 1 measurement with endotoxin adsorption therapy (PMX-DHP) for postoperative septic shock patients
por: Ikeda, T, et al.
Publicado: (2007)

Endotoxin hemadsorption in septic shock
por: Sunavala, Jamshed D., et al.
Publicado: (2014)

The role of endotoxin in septic shock
por: Kellum, John A., et al.
Publicado: (2023)

Early introduction of hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
por: Kushi, H, et al.
Publicado: (2005)

Induction of endotoxin (ET) tolerance by atoxic endotoxin - a new prophylactic concept to the septic syndrome
por: Staubach, K, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_thl50l3077huorvsdskil501vj